WS #1519

The data dump reveals escalating geopolitical tensions in the Middle East, with significant implications for energy and commodity markets. Multiple sources corroborate that Iran's strategic filtering in the Strait of Hormuz has caused a 90% drop in traffic, affecting over 30% of urea shipments and substantial portions of sulfur, ammonia, and phosphates, leading to price spikes (e.g., urea up 34.5% monthly). This is compounded by a pipeline leak and fire at Libya's Sharara oil field, which pumps ~300k barrels per day, tightening crude supply. Concurrently, discussions of international defense cooperation for the Strait and ICL Group's opening of a specialty fertilizer plant in India aim to mitigate disruptions, but the overall sentiment is bearish for energy security, likely impacting Brent crude and related ETFs like XLE. In corporate news, Ovid Therapeutics reported strong Q4 earnings, new clinical data for OV329, and a $60M private placement led by Point72, driving bullish sentiment for OVID. Needham maintained a Buy on Trevi Therapeutics and raised its price target to $24, supporting TRVI. NVIDIA faces bearish pressure due to concerns over China approval for its H200 AI chip and high valuations, with social media posts indicating short positions on NVDA. Other developments include IDEAYA Biosciences and Greenwich LifeSciences presenting data at AACR 2026, potentially benefiting IDYA and GLSI, and Waters pricing a $3.5B senior notes offering, which may affect WAT's debt profile.